Mechanisms of mucosal inflammation in the nose and lungs

Clinical and Experimental Allergy, Supplement

Volumn 28, Issue 2, 1998, Pages 11-16

  Durham, S R ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Allergen; Asthma; Corticosteroid; Eosinophilia; Fluticasone propionate; Inflammation; Interleukin 5; Interleukin 4; Rhinitis; T lymphocyte

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE; INTERLEUKIN 4; INTERLEUKIN 5; PREDNISOLONE;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; CONFERENCE PAPER; CORTICOSTEROID THERAPY; CYTOKINE RELEASE; EOSINOPHILIA; INFLAMMATION; LYMPHOCYTE ACTIVATION; MAST CELL DEGRANULATION; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TISSUE REACTION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; ASTHMA; GLUCOCORTICOIDS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-5; LEUKOCYTES; LUNG; NASAL MUCOSA; RHINITIS;

EID: 0031807631     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Baroody FM, Lee B-J, Lim MC, Bochner BS. Implicating adhesion molecules in nasal allergic inflammation. Eur Arch Otorhinolaryngol 1995; 252 (Suppl. 1): S50-S58.
2. Bousquet J, Vignola AM, Campbell AM, Michel F-B. Pathophysiology of allergic rhinitis. Int Arch Allergy Immunol 1996; 110: 207-19.
3. Barnes PJ. Biochemistry of asthma. Trends Biochem Sci 1991; 16: 365-9.
4. Howarth PH, Holmberg K. Allergic rhinitis: an increasing clinical problem. Allergy 1995; 50 (Suppl. 23): 4-5.
5. Aberg N, Sundell J, Eriksson B, Hesselmar B, Aberg B. Prevalence of allergic diseases in schoolchildren in relation to family history, upper respiratory infections, and residential characteristics. Allergy 1996; 51: 232-7.
6. Keil U, Weiland SK, Duhme H, Chambless L. The International study of asthma and Allergies in Childhood (ISAAC): objectives and methods; results from the German ISAAC centres concerning traffic density and wheezing and allergic rhinitis. Toxicol Lett 1996; 86: 99-103.
7. Aberg N. Birth season variation in asthma and allergic rhinitis. Clin Exp Allergy 1989; 19: 643-8.
8. Meltzer EO, Orgel HA, Rogenes PR, Field EA. Nasal cytology in patients with allergic rhinitis: Effects of intranasal fluticasone propionate. J Allergy Clin Immunol 1994; 94: 708-13.
9. Masuyama K, Jacobson MR, Rak S et al. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunol 1994; 82: 192-9.
10. Munk Z, Graft D, Green A et al. Fluticasone propionate is an effective treatment for seasonal allergic rhinitis in adolescents. Ann Allergy 1991; 66: 97 (abstr P46).
11. Banov C, Blumenthal M, Frazer H et al. Treatment of perennial allergic rhinitis with fluticasone propionate. Ann Allergy 1991; 66: 97 (abstr P48).
12. de Graaf-in't Veld C, Garrelds IM, van Wijk RG et al. The effect of intranasal fluticasone propionate (FP) on the immediate and late allergic nasal reaction and nasal hyperreactivity in patients with a house dust mite (HDM) allergy. Allergy 1993; 48 (Suppl. 16): 87.
13. Ortolani C, Bagnato G, Bonifazi F et al. Fluticasone propionate aqueous nasal spray once daily vs. nasal levocabastine twice daily vs. nasal placebo in the treatment of seasonal rhinitis. Am J Respir Crit Care Med 1997; 153 (Suppl.): A980.
14. Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli SJ, Lichtenstein LM. Basophil influx occurs after nasal allergen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988; 81: 580-9.
15. Durham SR, Ying S, Varney VA et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and GM-CSF in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148: 2390-4.
16. Ying S, Durham SR, Jacobson MR et al. T lymphocytes and mast cells express messenger for the interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunol 1994; 82: 200-6.
17. Ying S, Durham SR, Barkans J et al. T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis. Am J Respir Cell Mol Biol 1993; 9: 356-60.
18. Bradding P, Feather IH, Wilson S, Holgate ST, Howarth PH. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid. Am J Respir Crit Care Med 1995; 151: 1900-6.
19. Masuyama K, Jacobson MR, Rak S et al. Topical glucocorticosteroid inhibits cytokine messenger RNA expression for interleukin-4 in the nasal mucosa in allergic rhinitis. Clin Exp Allergy 1994; 24: 188.
20. Rak S, Jacobson MR, Sudderick RM et al. Influence of prolonged treatment with fluticasone propionate on allergen-induced early and late phase nasal responses. Clin Exp Allergy 1994; 24: 183.
21. Robinson D, Hamid Q, Bentley A et al. Activation of CD4+ T cells increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993; 92: 313-24.
22. Robinson D, Hamid Q, Ying S et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression. Am Rev Respir Dis 1993; 148: 401-6.
23. Wang D, Clement P, Duyck F. Effect and onset of action of intranasal fluticasone propionate on the mediator concentrations and eosinophil count in the nasal secretions of patients with seasonal allergic rhinitis after nasal allergen challenge: a double-blind, randomised placebo-controlled cross-over study. Eur Respir J 1996; 9 (Suppl. 23): 19S.
24. Weido AJ, Reece LM, Alam R, Cook CK, Sim TC. Intranasal fluticasone propionate inhibits recovery of chemokines and cytokines in nasal secretions in allergen-induced rhinitis. Ann Asthma Allergy Immunol 1996; 77: 407-15.
25. Alvarado-Valdes CA, Blomgren J, Weiler D et al. The effect of fluticasone propionate aqueous nasal spray on eosinophils and cytokines in nasal secretions of patients with ragweed allergic rhinitis. Clinr 1997; 2: 273-81.
26. Holm AF, Fokkens WJ, Godthelp T et al. Effect of 3 months' nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis. Allergy 1995; 50: 204-9.
27. Mygind N, Dahl R. The rationale for use of topical corticosteroids in allergic rhinitis. Clin Exp Allergy 1996; 26 (Suppl. 2): 2-10.